PL3837282T3 - Układy i sposoby elektroforezy kapilarnej powinowactwa - Google Patents

Układy i sposoby elektroforezy kapilarnej powinowactwa

Info

Publication number
PL3837282T3
PL3837282T3 PL19783175.3T PL19783175T PL3837282T3 PL 3837282 T3 PL3837282 T3 PL 3837282T3 PL 19783175 T PL19783175 T PL 19783175T PL 3837282 T3 PL3837282 T3 PL 3837282T3
Authority
PL
Poland
Prior art keywords
methods
electrophoresis systems
affinity electrophoresis
capillary affinity
capillary
Prior art date
Application number
PL19783175.3T
Other languages
English (en)
Inventor
Kelsey Catherine Dent
David John Fischer
David A. Michels
Original Assignee
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech, Inc. filed Critical Genentech, Inc.
Publication of PL3837282T3 publication Critical patent/PL3837282T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561Immunoelectrophoresis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/24Extraction; Separation; Purification by electrochemical means
    • C07K1/26Electrophoresis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44704Details; Accessories
    • G01N27/44717Arrangements for investigating the separated zones, e.g. localising zones
    • G01N27/44721Arrangements for investigating the separated zones, e.g. localising zones by optical means
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438Electrodes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31Immunoglobulins specific features characterized by aspects of specificity or valency multispecific

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Electrochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Electrostatic Separation (AREA)
PL19783175.3T 2018-09-10 2019-09-10 Układy i sposoby elektroforezy kapilarnej powinowactwa PL3837282T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862729384P 2018-09-10 2018-09-10
PCT/US2019/050361 WO2020055832A1 (en) 2018-09-10 2019-09-10 Systems and methods for affinity capillary electrophoresis

Publications (1)

Publication Number Publication Date
PL3837282T3 true PL3837282T3 (pl) 2026-02-16

Family

ID=68138779

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19783175.3T PL3837282T3 (pl) 2018-09-10 2019-09-10 Układy i sposoby elektroforezy kapilarnej powinowactwa

Country Status (12)

Country Link
EP (2) EP3837282B1 (pl)
JP (1) JP7482853B2 (pl)
KR (1) KR102831943B1 (pl)
CN (1) CN112654639B (pl)
BR (1) BR112021004436A2 (pl)
CA (1) CA3109067A1 (pl)
ES (1) ES3041610T3 (pl)
IL (1) IL281186A (pl)
MX (1) MX2021002573A (pl)
PL (1) PL3837282T3 (pl)
TW (1) TWI850255B (pl)
WO (1) WO2020055832A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025249551A1 (ja) * 2024-05-31 2025-12-04 中外製薬株式会社 二重特異性抗体のミスペア軽鎖交換体の定量方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2828426B2 (ja) * 1995-03-31 1998-11-25 株式会社分子バイオホトニクス研究所 蛍光検出等電点電気泳動用マーカー
US20020062010A1 (en) 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
US20030207346A1 (en) * 1997-05-02 2003-11-06 William R. Arathoon Method for making multispecific antibodies having heteromultimeric and common components
ES2246069T3 (es) 1997-05-02 2006-02-01 Genentech, Inc. Procedimiento de preparacion de anticuerpos multiespecificos que tienen componentes comunes y multimericos.
US6284540B1 (en) 1998-09-29 2001-09-04 Washington University Artemin, a novel neurotrophic factor
CA2463301A1 (en) * 2004-04-22 2005-10-22 Atanas Iliev Lalev Method for detecting protein interactions - affinity purification with switching the ligand
JP2009541275A (ja) 2006-06-22 2009-11-26 ノボ・ノルデイスク・エー/エス 二重特異性抗体の生産
US8592562B2 (en) 2008-01-07 2013-11-26 Amgen Inc. Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects
DK2766392T3 (da) 2011-10-10 2019-10-07 Xencor Inc Fremgangsmåde til oprensning af antistoffer
US10851178B2 (en) 2011-10-10 2020-12-01 Xencor, Inc. Heterodimeric human IgG1 polypeptides with isoelectric point modifications
AR096601A1 (es) 2013-06-21 2016-01-20 Novartis Ag Anticuerpos del receptor 1 de ldl oxidado similar a lectina y métodos de uso
KR102357961B1 (ko) 2013-12-17 2022-02-08 제넨테크, 인크. 항-cd3 항체 및 이의 사용 방법
JP7240812B2 (ja) 2015-05-12 2023-03-16 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 多量体タンパク質の純度の決定
EP3352760B1 (en) * 2015-09-21 2026-03-11 Aptevo Research and Development LLC Cd3 binding polypeptides

Also Published As

Publication number Publication date
EP3837282A1 (en) 2021-06-23
EP3837282C0 (en) 2025-08-27
KR102831943B1 (ko) 2025-07-10
JP7482853B2 (ja) 2024-05-14
BR112021004436A2 (pt) 2021-05-25
CA3109067A1 (en) 2020-03-19
KR20210056364A (ko) 2021-05-18
MX2021002573A (es) 2021-05-12
AU2019340647A1 (en) 2021-03-11
WO2020055832A1 (en) 2020-03-19
CN112654639A (zh) 2021-04-13
EP3837282B1 (en) 2025-08-27
EP4660623A2 (en) 2025-12-10
ES3041610T3 (en) 2025-11-13
JP2022500627A (ja) 2022-01-04
CN112654639B (zh) 2024-08-30
TW202026314A (zh) 2020-07-16
IL281186A (en) 2021-04-29
TWI850255B (zh) 2024-08-01

Similar Documents

Publication Publication Date Title
IL283169A (en) Crispr-cas12j enzyme and system
IL284748A (en) Anti-cyberbullying systems and methods
IL282362A (en) Intein proteins and uses thereof
HRP20251600T1 (hr) Sustav i postupci
EP3826373A4 (en) POWER CONTROL PROCESS AND DEVICE
EP3742474C0 (en) BONDING SYSTEM AND BONDING METHOD
PL3694529T3 (pl) Trójswoiste białka i sposoby zastosowania
IL268593A (en) Polypeptide variants and uses thereof
EP3850455C0 (en) CONTROL AND NAVIGATION SYSTEMS
IL281060A (en) Systems and methods of optimal metrology guidance
DK3746225T3 (da) Analytiske systemer og fremgangsmåder
EP3810172A4 (en) Heterodimeric proteins and uses thereof
PL3565828T3 (pl) Białko fuzyjne SIRP1 ALFA-41BBL i sposoby jego zastosowania
IL281297A (en) Anti-npr1 antibodies and uses thereof
EP3601146A4 (en) CARBONATION REDUCTION SYSTEMS AND METHODS
IL283875A (en) Anti-il-27 antibodies and uses thereof
EP4049241A4 (en) METHODS AND SYSTEMS FOR INFORMATION SHEET ANALYSIS
IL268542A (en) Joint and fluid control device
EP3672443A4 (en) SUITCASE AND SUITCASE SYSTEM
EP4159853A4 (en) GENOME EDITING SYSTEM AND METHOD
EP3722305A4 (en) HM-3 FUSION PROTEIN AND USES THEREOF
IL283235A (en) Systems and methods for purifying solvents
IL280446A (en) A system and a method for building a road
EP4027931C0 (en) NAVIGATION UNIT AND PROCESS
DK3714215T3 (da) Affugtningssystem og -fremgangsmåde